Poly(D, l-lactic acid) (PDLLA)/β-tricalcium phosphate (β-TCP) nerve conduits filled by injectable chitosan (CS)/hyaluronic acid (HA) hydrogels with NGF |
Sustained NGF release; supports neuronal cell adhesion, spreading, and differentiation |
Peripheral nerve injury |
[26] |
Hydrogel-enriched chitosan conduits with Schwann cells containing glial cell line-derived neurotrophic factor (GDNF) and fibroblast growth factor 2 (FGF-2) |
Biocompatible; supports axonal outgrowth, SC viability, cellular neurotrophic factor delivery system |
Peripheral nerve injury |
[46] |
PHEMA-MMA tubes with collagen gel and growth factors (neurotropin-3, brain-derived neurotrophic factor (BDNF), and acidic fibroblast growth factor (FGF-1)) |
Supports nerve regeneration; biostable, biocompatible, improved regeneration with growth factors |
Peripheral nerve injury |
[47] |
Chitosan/beta-glycerophosphate-NGF hydrogel |
Continuous NGF release, improved nerve recovery, thicker myelin sheaths |
Facial nerve injury |
[49] |
Mesenchymal stem cell-laden fibrin hydrogel microfibers |
Mimic nerve tissue, control stem cell behavior, improve motor function, and promote integration with the host tissue |
Spinal cord injury |
[50] |
Injectable thermosensitive CS/beta-GP/HEC hydrogel containing nerve growth factor (NGF)-overexpressing hADSCs |
Increased cell proliferation, smaller cavity size, better locomotor functions |
Spinal cord injury |
[68] |
Erythropoietin (EPO)-loaded multifunctional hydrogel with adipose-derived stem cells (ADSCs) |
Adhesive, high mechanical strength, sustained release; enhances cell retention, supports nerve regeneration, reduces astrocyte development |
Neurogenic erectile dysfunction |
[69] |
Poloxamer hydrogel with adipose-derived stem cells (ASCs) |
Promotes axonal regrowth, supports muscle reinnervation; beneficial immunomodulation |
Peripheral nerve injury |
[70] |
Heparin/Poloxamer thermosensitive hydrogel loaded with bFGF and NGF |
Provides supportive environment to restore structure, enables sustained release of growth factors, enhances axonal regeneration, supports Schwann cell proliferation |
Peripheral nerve injury in diabetic rats |
[71] |
Decellularized porcine nerve-derived hydrogel (PNM) |
Maintains nerve-specific matrix components and growth factors, improves electrophysiologic response and axon counts |
Nerve gap injury |
[72] |
Decellularized nerve matrix hydrogel derived from porcine sciatic nerve with microchannels (A-pDNM-G) |
Longitudinally oriented microchannels, promotion of neurite extension and Schwann cell migration, controlled release of neurotrophic factors |
Peripheral nerve injury |
[73] |
Fibrin hydrogel with tacrolimus and mesenchymal stem cells (MSC) |
Sustained and localized drug release; supports MSC viability, enhances peripheral nerve regeneration |
Peripheral nerve injury |
[74] |
Gelatin hydrogel with olfactory stem cells (OSC) |
Biodegradable; aids cell survival during transplantation, promotes axonal regeneration, increases number of regenerated nerve fibers |
Facial nerve injury |
[75] |